BRUKER CORPORATION (BRKR) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 1.81B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities |
| Total assets | 6.05B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $1.81B | (m) | (m) | $6.05B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $1.66B | (m) | (m) | $6.13B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $1.85B | (m) | (m) | $6.24B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $1.98B | (m) | (m) | $6.43B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $2.38B | (m) | (m) | $6.34B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $2.08B | (m) | (m) | $5.93B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $2.06B | (m) | (m) | $5.81B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $2.26B | (m) | (m) | $6.11B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $2.13B | (m) | (m) | $5.90B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $1.36B | (m) | (m) | $4.51B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $1.16B | (m) | (m) | $4.25B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $1.10B | (m) | (m) | $3.82B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $1.12B | (m) | (m) | $3.86B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $1.11B | (m) | (m) | $3.76B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $1.20B | (m) | (m) | $3.61B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $1.14B | (m) | (m) | $3.34B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $1.17B | (m) | (m) | $3.38B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $1.21B | (m) | (m) | $3.55B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $1.22B | (m) | (m) | $3.65B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $717.50M | (m) | (m) | $3.13B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $721.10M | (m) | (m) | $3.09B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $715.80M | (m) | (m) | $3.03B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $842.30M | (m) | (m) | $3.05B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $828.20M | (m) | (m) | $2.88B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $924.20M | (m) | (m) | $2.94B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $914.80M | (m) | (m) | $2.96B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $812.80M | (m) | (m) | $2.77B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $518.50M | (m) | (m) | $2.35B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $493.90M | (m) | (m) | $2.35B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $322.60M | (m) | (m) | $2.13B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |